SIM
MCRB icon

Spark Investment Management’s Seres Therapeutics MCRB Stock Holding History

Spark Investment Management’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,682
Closed -$633K – 710
2018
Q2 		$633K Sell
3,682
-293
-7% -$47.9K 0.04% 417
2018
Q1 		$583K Buy
3,975
+1,440
+57% +$276K 0.04% 388
2017
Q4 		$514K Buy
+2,535
New +$521K 0.03% 451
2017
Q2 		– Sell
-2,720
Closed -$613K – 824
2017
Q1 		$613K Buy
+2,720
New +$552K 0.04% 498

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Spark Investment Management's MCRB Position: Q3 2018 in Review

Spark Investment Management sold out of Seres Therapeutics (MCRB) in Q3 2018, closing a stake of 3,682 shares — an estimated $633K sold.

Spark Investment Management first reported a position in MCRB in Q1 2017 and held it in 4 quarters. The position peaked at $633K in Q2 2018. 72 funds tracked by Wall St. Rank hold MCRB as of Q3 2018.

  • Spark Investment Management reported no remaining Seres Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Spark Investment Management sold 3,682 Seres Therapeutics shares in Q3 2018, an estimated $633K.
  • Spark Investment Management first reported a position in Seres Therapeutics in Q1 2017 and held it in 4 quarters.
  • Spark Investment Management's Seres Therapeutics position peaked at $633K in Q2 2018.
  • 72 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2018.

Based on Spark Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.